Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
Clinical trial NCT05054140 · UNKNOWN
Trial details
- NCT number
- NCT05054140
- Sponsor
- Immunic AG
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2025-01-07
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.